Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 18;12(3):755.
doi: 10.3390/jcm12030755.

Radiation Exposure and Surgical Outcomes after Antegrade Sclerotherapy for the Treatment of Varicocele in the Paediatric Population: A Single Centre Experience

Affiliations

Radiation Exposure and Surgical Outcomes after Antegrade Sclerotherapy for the Treatment of Varicocele in the Paediatric Population: A Single Centre Experience

Carolina Bebi et al. J Clin Med. .

Abstract

Introduction: Antegrade sclerotherapy (Tauber) effectively treats varicocele. However, fluoroscopy exposes young males to ionizing radiation. We aimed to evaluate radiation exposure and surgical outcomes after the Tauber procedure.

Materials and methods: We retrospectively analysed data from 251 patients. Dose area product (DAP) and fluoroscopy time were recorded. The effective dose was calculated with the PCXMC software. Descriptive statistics and linear regression tested the association between clinical predictors and radiation exposure.

Results: Median (IQR) age and body mass index (BMI) were 14 (13-16) years and 20.1 (17.9-21.6) kg/m². Five (2.1%) patients developed clinical recurrence and two (0.81%) developed complications. Median fluoroscopy time and DAP were 38.5 (27.7-54.0) s and 89.6 (62.5-143.9) cGy*cm2. The effective dose was 0.19 (0.14-0.31) mSv. Fluoroscopy time was higher in patients with collateral veins (41 (26-49) s vs. 36 (31-61) s, p = 0.02). The median amount of sclerosing agent (SA) used was 3 (3-4) ml. DAP was higher when SA > 3 mL was used (101.4 (65-183) cGy*cm2 vs. 80.5 (59-119) cGy*cm2; p < 0.01). At univariable linear regression, age, BMI, operative time and SA > 3 mL were associated with higher DAP (all p < 0.01). At multivariable linear regression, only BMI (beta 12.9, p < 0.001) and operative time (beta 1.9, p < 0.01) emerged as predictors of higher DAP, after accounting for age and SA > 3 mL.

Conclusions: The Tauber procedure is safe and associated with low effective doses. Operative time and the patient's BMI independently predict a higher radiation dose.

Keywords: Tauber procedure; antegrade sclerotherapy; fluoroscopy; male infertility; paediatric varicocele; radiation exposure; varicocele.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Akbay E., Çayan S., Doruk E., Duce M., Bozlu M. The prevalence of varicocele and varicocele-related testicular atrophy in Turkish children and adolescents. BJU Int. 2000;86:490–493. doi: 10.1046/j.1464-410X.2000.00735.x. - DOI - PubMed
    1. World Health Organization The influence of varicocele on parameters of fertility in a large group of men presenting to infertility clinics. Fertil. Steril. 1992;57:1289–1293. doi: 10.1016/S0015-0282(16)55089-4. - DOI - PubMed
    1. Laven J.S., Haans L.C., Mali W.P., Velde E.R.T., Wensing C.J., Eimers J.M. Effects of varicocele treatment in adolescents: A randomized study. Fertil. Steril. 1992;58:756–776. doi: 10.1016/S0015-0282(16)55324-2. - DOI - PubMed
    1. Nork J.J., Berger J.H., Crain D.S., Christman M.S. Youth varicocele and varicocele treatment: A meta-analysis of semen outcomes. Fertil. Steril. 2014;102:381–387.e6. doi: 10.1016/j.fertnstert.2014.04.049. - DOI - PubMed
    1. Silay M.S., Hoen L., Quadackaers J., Undre S., Bogaert G., Dogan H.S., Kocvara R., Nijman R.J., Radmayr C., Tekgul S., et al. Treatment of Varicocele in Children and Adolescents: A Systematic Review and Meta-analysis from the European Association of Urology/European Society for Paediatric Urology Guidelines Panel. Eur. Urol. 2019;75:448–461. doi: 10.1016/j.eururo.2018.09.042. - DOI - PubMed

LinkOut - more resources